RESUMO
Zinc oxide nanoparticles (ZnO NPs) have been successfully prepared using Cocos nucifera leaf extract and their antimicrobial, antioxidant and photocatalytic activity investigated. The structural, compositional and morphological properties of the NPs were recorded and studied systematically to confirm the synthesis. The aqueous suspension of NPs showed an ultraviolet-visible (UV-Vis) absorption maxima of 370 nm, indicating primarily its formation. X-ray diffraction analysis identified the NPs with a hexagonal wurtzite structure and an average particle size of 16.6 nm. Fourier transform infrared analysis identified some biomolecules and functional groups in the leaf extract as responsible for the encapsulation and stabilization of ZnO NPs. Energy-dispersive X-ray analysis showed the desired elemental compositions in the material. A flower-shaped morphology of ZnO NPs was observed by scanning electron microscopy, with a grain size of around 15 nm. The optical properties of the NPs were studied by UV-Vis spectroscopy, and the band gap was calculated as 3.37 eV. The prepared ZnO NPs have demonstrated antimicrobial activity against T. harzianum and S. aureus, with a zone of inhibition of 14 and 10 mm, respectively. The photocatalytic behaviour of ZnO NPs showed absorbance degradation at around 640 nm and it discoloured methylene blue dye after 1 h, with a degradation maximum of 84.29%. Thus, the prepared ZnO NPs could potentially be used in antibiotic development and pharmaceutical industries, and as photocatalysts.
RESUMO
The dimeric complex acetato(eta4-cycloocta-1,5-diene)rhodium(I), [Rh(O2CMe)(eta4-cod)]2 (cod = cycloocta-1,5-diene) reacts with N,O-chelating Schiff-base ligands or with N-phenylglycine to afford the diminato- or aminocarboxylato(4-cycloocta-1,5-diene)rhodium(I) complexes [{Rh(eta4-cod)}2(salen)] (1), [{Rh(eta4-cod)}2(salophen)] (2), [Rh((S)-N-phenylglycinato)(eta4-cod)] (3S), [Rh(rac-N-phenylglycinato)(eta4-cod)] (3rac), [Rh((R)-N-(4-methoxphenyl)ethyl-2-oxo-1-naphthaldiminato)(eta4-cod)] (4) and [Rh(N-(o-tolyl)-2-oxo-1-naphthaldiminato)(eta4-cod)] (5) [salen2- = N,N-ethylene-bis(salicylaldiminato), salophen2- = N,N-(1,2-phenylene)-bis(salicylaldiminato)]. The complexes are characterized by IR-, UV/Vis-, 1H/13C-NMR- and mass-spectroscopy. Complexes 1, 2, 4 and 5 contain six-membered metallaaromatic Rh-(N-CCC-O)-chelate rings which accept C-H...pi contacts. The crystal structure of 2 presents a polymorph (dimorph) (2a) to a previously reported structure (2b, CSD refcode SCLIRB10). Polymorphic forms 2a and 2b are traced to a different interlocking of adjacent dinuclear molecules with their corrugated van der Waals surface. The achiral N-phenylglycine ligand gives a chiral N-phenylglycinato complex [Rh(O2C-CH2-NHPh)(eta4-cod)] (3) with the nitrogen atom becoming the stereogenic center upon metal coordination. Complex 3 can crystallize as the enantiomorph 3S in the tetragonal, chiral space group P41 in a spontaneous resolution of the racemic mixture into homo-chiral helix-enantiomers due to inter-molecular N-H...O hydrogen bonding which connects only molecules of the same (S-) configuration into (right-handed or P-) 41-helical chains. Variation of the crystallization conditions gives 3 as a racemic polymorphic 3rac. R- and S-complexes 3 assemble in the polymorph 3rac in parallel chains along the 21-axes through N-HO hydrogen bonding. Again, only molecules of the same configuration are combined into a chain, albeit neighboring chains have complexes of opposite configuration. The chiral enantiomeric naphthaldiminato complex 4 displays a herring-bone arrangement. Achiral compound 5 crystallizes in the non-centrosymmetric polar space group Cc where all molecules show the same orientation.
